BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15100504)

  • 1. The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy.
    Schaffland AO; Delaloye AB; Kosinski M; Dupertuis YM; Buchegger F
    Nucl Med Commun; 2004 May; 25(5):461-8. PubMed ID: 15100504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
    Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
    Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
    Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridine.
    Buchegger F; Vieira JM; Blaeuenstein P; Dupertuis YM; Schaffland AO; Grannavel C; de Tribolet N; Slosman DO; Bischof Delaloye A
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):239-46. PubMed ID: 12552342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FLT and 125I-IdUrd uptake increase in human tumour cell lines induced by the thymidylate synthase inhibitor FdUrd.
    Viertl D; Perillo-Adamer F; André PA; Ametamey SM; Ross TL; Kosinski M; Dupertuis YM; Bischof Delaloye A; Buchegger F
    Nuklearmedizin; 2012; 51(5):163-9. PubMed ID: 22576273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans.
    Kassis AI; Van den Abbeele AD; Wen PY; Baranowska-Kortylewicz J; Aaronson RA; DeSisto WC; Lampson LA; Black PM; Adelstein SJ
    Cancer Res; 1990 Aug; 50(16):5199-203. PubMed ID: 2379179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT.
    Vogg AT; Buck AK; Schmid M; Neumaier B; Wczasek K; Zlatopolskiy BD; Reske SN
    Nucl Med Biol; 2007 Apr; 34(3):273-81. PubMed ID: 17383577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of radioiodinated nucleoside analogs for imaging tissue proliferation: comparisons of six 5-iodonucleosides.
    Toyohara J; Hayashi A; Sato M; Gogami A; Tanaka H; Haraguchi K; Yoshimura Y; Kumamoto H; Yonekura Y; Fujibayashi Y
    Nucl Med Biol; 2003 Oct; 30(7):687-96. PubMed ID: 14499326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts.
    Buchegger F; Adamer F; Schaffland AO; Kosinski M; Grannavel C; Dupertuis YM; de Tribolet N; Mach JP; Delaloye AB
    Int J Cancer; 2004 May; 110(1):145-9. PubMed ID: 15054880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
    Kersemans V; Cornelissen B; Kersemans K; Bauwens M; Achten E; Dierckx RA; Mertens J; Slegers G
    J Nucl Med; 2005 Mar; 46(3):532-9. PubMed ID: 15750170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of (131/123)I-5-iodo-2'-deoxycytidine as a novel proliferation probe in a tumor mouse model.
    Chang WY; Kuo WT; Wu CY; Lin CY; Chan PC; Shen CC; Liu RS; Wang HE; Chen CL
    Appl Radiat Isot; 2013 Jul; 77():166-73. PubMed ID: 23602704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diesterified derivatives of 5-iodo-2'-deoxyuridine as cerebral tumor tracers.
    Rösler TW; Matusch A; Librizzi D; Arias-Carrión O; Freundlieb N; Hoeffken H; Oertel WH; Depboylu C; Höglinger GU
    PLoS One; 2014; 9(7):e102397. PubMed ID: 25028935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instantaneous preparation of radiolabeled 5-iodo-2'-deoxyuridine.
    Foulon CF; Zhang YZ; Adelstein SJ; Kassis AI
    Appl Radiat Isot; 1995 Oct; 46(10):1039-46. PubMed ID: 7496371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific endothelial binding and tumor uptake of radiolabeled angiostatin.
    Lee KH; Song SH; Paik JY; Byun SS; Lee SY; Choe YS; Kim BT
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1032-7. PubMed ID: 12557052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.
    Kassis AI; Tumeh SS; Wen PY; Baranowska-Kortylewicz J; Van den Abbeele AD; Zimmerman RE; Carvalho PA; Garada BM; DeSisto WC; Bailey NO; Castronovo FP; Mariani G; Black PM; Adelstein SJ
    J Nucl Med; 1996 Apr; 37(4 Suppl):19S-22S. PubMed ID: 8676198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive in vivo imaging with radiolabelled FIAU for monitoring cancer gene therapy using herpes simplex virus type 1 thymidine kinase and ganciclovir.
    Deng WP; Yang WK; Lai WF; Liu RS; Hwang JJ; Yang DM; Fu YK; Wang HE
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):99-109. PubMed ID: 14513292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodination and radiolabeling of alpha-allocryptopine with iodine-125.
    Wei Y; Wei X; Wang Y; Liu X; Chu T; Hu S; Wang X
    Appl Radiat Isot; 2005 Jan; 62(1):55-62. PubMed ID: 15498685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.